Effects of safinamide on pain in patients with fluctuating Parkinson's disease

BACKGROUND: Non‐motor symptoms (NMS) are integral to Parkinson's Disease (PD) and management remains a challenge. Safinamide is a novel molecule in relation to addressing NMS due to its multifocal mechanism of action with both dopaminergic and non‐dopaminergic properties. OBJECTIVE: To investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigoriou, Sotirios, Martínez‐Martín, Pablo, Ray Chaudhuri, K., Rukavina, Katarina, Leta, Valentina, Hausbrand, Denise, Falkenburger, Björn, Odin, Per, Reichmann, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553314/
https://www.ncbi.nlm.nih.gov/pubmed/34478245
http://dx.doi.org/10.1002/brb3.2336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553314/
https://www.ncbi.nlm.nih.gov/pubmed/34478245
http://dx.doi.org/10.1002/brb3.2336

Ejemplares similares